Nykode Therapeutics AS (VACBF) Q2 2024 Earnings

14MayConfirmed
Q4 2023
Q2 2024
-0.05
-0.04
-0.03
-0.02

Details

Expected EPS
-0.046242
Actual EPS
-0.047358
Surprise EPS
-0
Surprise Percent
+2.41%

Description

Nykode Therapeutics AS (VACBF) has reported earnings of -0.047358 per share for Q2 2024.

0 Comments

Share your thoughts